SCHEMBL3910792

SCHEMBL3910792

NC(=O)c1cc(Cl)ccc1C(=O)N1CCCC2CCCCC21

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 8/20 0.51
DRD2 P14416 1/20 0.46
DRD4 P21917 1/20 0.46
POLB P06746 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
HSD17B1 P14061 1/20 0.42
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
CNR2 P34972 1/20 0.41
BTK Q06187 2/20 0.39
DPP4 P27487 1/20 0.38
PREP P48147 1/20 0.38
FAP Q12884 1/20 0.38
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
GLA P06280 1/20 0.38
GAA P10253 1/20 0.38
HSP90AA1 P07900 1/20 0.37
HSP90AB1 P08238 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3910795 0.87 HSD11B1 (0.53) HSD11B1DRD2DRD4POLBTDP1
SCHEMBL3904098 0.82 HSD11B1 (0.56) HSD11B1POLBNPC1RAB9ASMN1; SMN2
SCHEMBL3901085 0.81 HRH3 (0.46) HSD11B1POLBNPC1RAB9ADPP4
SCHEMBL3913108 0.79 CNR2 (0.48) RAB9ACNR2GLA
SCHEMBL5663191 0.78 HSD11B1 (0.48) HSD11B1DRD2DRD4POLBTDP1
SCHEMBL5663190 0.75 HSD11B1 (0.48) HSD11B1DRD2DRD4POLBTDP1
SCHEMBL3899814 0.75 KDM4E (0.51) POLBNPC1RAB9ASMN1; SMN2CNR2
SCHEMBL3903749 0.75 KDM4E (0.51) POLBNPC1RAB9AKDM4EALDH1A1
SCHEMBL3901377 0.74 RAB9A (0.52) HSD11B1POLBNPC1RAB9AKDM4E
SCHEMBL3900298 0.74 RAB9A (0.52) HSD11B1POLBNPC1RAB9AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7241759-B2 Benzo[1,2,5]thiadiazole compounds JANSSEN PHARMACEUTICA N.V. (BE) 2007-07-10 US claimed
US-7550492-B2 Benzo[1,2,5]thiadiazole compounds JANSSEN PHARMACEUTICA N.V. (BE) 2009-06-23 US disclosed
US-20070276016-A1 BENZO[1,2,5]THIADIAZOLE COMPOUNDS JANSSEN PHARMACEUTICA N.V. (BE) 2007-11-29 US disclosed
US-7241759-B2 Benzo[1,2,5]thiadiazole compounds JANSSEN PHARMACEUTICA N.V. (BE) 2007-07-10 US disclosed
US-20040224983-A1 Benzo[1,2,5]thiadiazole compounds JANSSEN PHARMACEUTICA, N.V. (BE) 2004-11-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070276016-A1 BENZO[1,2,5]THIADIAZOLE COMPOUNDS CCKBR, CCKAR, GIPR HSD11B1 1590/4885DRD2 3072/4885DRD4 4190/4885
US-20040224983-A1 Benzo[1,2,5]thiadiazole compounds CCKBR, CCKAR, BRSK2 HSD11B1 1033/4885DRD2 1583/4885DRD4 3092/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.